BeOne Medicines AG (ONC)

BeOne Medicines AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	11,353	6,948	3,183	3,870	4,376
Short-Term Investments	2,413	938.89	2.6	665.25	2,242
Cash & Short-Term Investments	13,766	7,887	3,186	4,535	6,618
Cash Growth	74.53%	147.57%	-29.75%	-31.47%	42.29%
Accounts Receivable	1,716	1,345	358.03	173.17	483.11
Other Receivables	14.16	32.57	-	-	-
Total Trade Receivables	1,730	1,378	358.03	173.17	483.11
Inventory	610.13	490.52	416.12	282.35	242.63
Other Current Assets	363.51	339.89	243.39	216.55	270.17
Total Current Assets	12,468	7,952	4,203	5,207	7,614
Net Property, Plant & Equipment	3,433	3,291	1,419	955.91	705.04
Other Intangible Assets	240.98	210.89	57.14	40.62	46.68
Long-Term Investments	61.86	127.27	-	-	-
Other Long-Term Assets	174.64	208.73	125.36	175.69	169.93
Total Assets	16,379	11,789	5,805	6,379	8,536
Accounts Payable	1,213	1,008	315.11	294.78	262.4
Accrued Expenses	1,592	1,192	693.73	467.35	558.06
Short-Term Debt	114.59	2,510	688.37	328.97	427.57
Current Portion of Long-Term Debt	202.16	161.59	-	-	-
Current Portion of Leases	20.7	17.58	21.95	24.04	21.93
Unearned Revenue	36.11	-	-	213.86	187.41
Other Current Liabilities	505.78	370.05	90.96	139.52	142.2
Total Current Liabilities	3,628	4,407	1,810	1,469	1,600
Long-Term Debt	6,685	2,536	197.62	209.15	202.11
Long-Term Leases	106	88.46	22.25	34.52	43.04
Other Long-Term Liabilities	1,191	481.52	237.97	283.74	558.25
Total Long-Term Liabilities	4,011	737.67	457.84	527.41	803.41
Total Liabilities	7,639	5,145	2,268	1,996	2,403
Common Stock	0.28	0.27	0.14	0.14	0.13
Additional Paid-in Capital	25,716	23,757	11,599	11,541	11,191
Accumulated Other Comprehensive Income	92.27	79.83	-99.45	-77.42	17.95
Retained Earnings	-17,068	-17,192	-7,962	-7,080	-5,077
Total Common Shareholders' Equity	8,741	6,644	3,537	4,383	6,133
Shareholders' Equity	4,379	3,312	3,537	4,383	6,133
Total Liabilities & Equity	16,379	11,789	5,805	6,379	8,536
Total Debt	7,129	5,313	930.19	596.68	694.64
Net Cash (Debt)	6,637	2,574	2,256	3,938	5,923
Net Cash Growth	157.86%	14.11%	-42.73%	-33.51%	44.86%
Net Cash Per Share	58.50	24.45	21.61	38.19	63.84
Book Value	8,741	6,644	3,537	4,383	6,133
Book Value Per Share	77.04	63.11	33.89	42.50	66.09
Tangible Book Value	8,500	6,433	3,480	4,343	6,086
Tangible Book Value Per Share	74.92	61.10	33.34	42.11	65.59

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q